The source cultivation of Chinese herbal medicines continues to heat up, and the supply of medicinal herbs increases rapidly, which will cause certain price fluctuations in the medicinal herbs market.

(Image source: panoramic vision)

With the "National Authentic Medicinal Material Production Base Construction Plan (With the promulgation of "2018-2025)" and the national "precise poverty alleviation" action arrangement, poverty alleviation in the Chinese herbal medicine industry is in full swing nationwide, and more authentic medicinal material production areas and suitable introduction areas will carry out large-scale Chinese herbal medicine planting activities. Objectively speaking, the policies issued by various ministries and commissions will undoubtedly further promote the development of the Chinese medicine industry, and the domestic and international Chinese medicine consumer market will also further expand. However, the source of Chinese herbal medicine cultivation continues to heat up, the rapid increase in the supply of medicinal materials, will also cause certain price fluctuations in the medicinal materials market.

Therefore, in the face of the new year's industrial environment, in the context of both opportunities and challenges, Chinese medicine companies should be keenly aware of the importance of the source of the industry to the upstream and downstream of the entire industry. Especially in the business involving the front end of traditional Chinese medicine, we should pay more attention to the construction of medicinal base and planting cooperation to ensure the quality of raw materials. Another fact that cannot be ignored is that although the quality of Chinese medicinal materials and decoction pieces has been improved as a whole at this stage, the rapid expansion of the planting volume may be accompanied by blind introduction and expansion, which will inevitably cause the quality of medicinal materials to a certain extent. The good and the bad are intermingled.

It is true that high-quality medicinal materials are always accompanied by high prices. In the market, the most direct reflection will be that high-quality medicinal resources continue to maintain a high price, or even a premium. Medicinal materials of relatively poor quality will face continued low prices or price cuts, and a gradual backlog of difficult to sell. Extending to downstream pharmaceutical companies may directly lead to fluctuations in the price of pharmaceutical raw materials brought about by rising prices of medicinal materials.

Shengshi Baicao as a modern Chinese medicine agricultural leading enterprises. Over the years, the development and control of high-quality Chinese herbal medicine resources has been the core of the cause. InIn 2019, we will continue to standardize and strengthen the traceability and control of the whole process of front-end planting, harvesting and primary processing, processing and production, testing and logistics of products. Further advocate the production of high-quality Chinese herbal medicines, leading the industry into the "pollution-free era".

(Source: Economic Observation Network）